Recent Ad Hoc Grant: Identifying new treatments for Kabuki syndrome type 2
Funding Amount
$66,500
Deadline
Deadline not published
Grant Type
Foundation
Deadline history & next window
- Cycle
- One-time opportunity
- Tracked since
- April 2026
Source: the cycle recorded on this listing. Confirm dates with the funder.
Overview
Identifying New Treatments for Kabuki Syndrome Type 2
Award Date: March 2025
This project aims to discover potential treatments for Kabuki syndrome type 2 (KS2) using Unravel Biosciences' proprietary bioinformatics platform, BioNAV™.
Research Focus
- Analysis of RNAseq data from nasal swabs of KS2 patients and matched controls
- Identification of differentially expressed genes, pathways, and potential therapeutic targets
- Prediction of compounds (including FDA-approved and GRAS compounds) capable of restoring disrupted RNA networks
- Patient stratification into Therapeutic Response Groups based on predicted response mechanisms
- Drug repurposing strategies and future clinical trial design
Researcher
Recipient: Unravel Biosciences
Contact
Address: P.O. Box 214, Northbrook, IL 60065
What Kabuki Syndrome Foundation actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 3
- Total given
- $239K
- Median grant
- $101K
- Range
- $29K–$109K
- By dollars: Maryland 46%, Massachusetts 42%, Washington 12%. Top recipient cities: Baltimore, MD; Boston, MA; Seattle, WA.
Example grants
Kennedy Krieger Institute · Baltimore, MD
Kabuki syndrome research
$109K
Boston Childrens Hospital · Boston, MA
Kabuki syndrome research
$101K
Seattle Children's Hospital · Seattle, WA
Kabuki syndrome research
$29K
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Discovery Grant
Kabuki Syndrome Foundation
Amount
$150,000
Deadline
Deadline not published
Recent Ad Hoc Grant: Optimizing BHB supplementation for cognitive improvement in Kabuki syndrome
Kabuki Syndrome Foundation
Amount
$45,000
Deadline
Deadline not published
Ad Hoc Research Funding / Letter of Intent (LOI) Program
Kabuki Syndrome Foundation
Amount
Varies
Deadline
Deadline not published
Recent Ad Hoc Grant: ZEPIKActive - dCas9 activator for KMT2D function restoration
Kabuki Syndrome Foundation
Amount
$45,132.96
Deadline
Deadline not published
Therapy Development Fund
Kabuki Syndrome Foundation
Amount
$150,000 - $250,000
Deadline
Deadline not published
AASM Foundation Strategic Research Award
American Academy of Sleep Medicine Foundation
Amount
Up to $250K
Deadline
Deadline not published
Ready to apply for Recent Ad Hoc Grant: Identifying new treatments for Kabuki syndrome type 2?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Recent Ad Hoc Grant: Identifying new treatments for Kabuki syndrome type 2. Now let's win it.